Clinical Trial Update: Study of ADXS11-001 in Participants With High Risk Locally Advanced Cervical Cancer [Phase 3]

View source ↗

Summary

Phase 3 study of ADXS11-001 in high-risk locally advanced cervical cancer was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• ADXS11-001

Snippet

Sponsor: Advaxis, Inc. | Conditions: High Risk Cervical Cancer, Advanced Cervical Cancer | Phase 3 | Status: TERMINATED | Results posted: 2023-03-14